GLP-1 weight loss drugs have quickly moved from medical journals to household conversations, reshaping how Americans think about obesity, diabetes and weight loss. Headlines often describe them as ...

Stimulant medications like methylphenidate (Ritalin) and lisdexamfetamine (Vyvanse) are dispensed at a rate of 6.1 prescriptions per 100 Americans annually, rising to 24.6 per 100 among boys aged ...

Variants in GLP‑1 and GIP receptor genes partly determine weight loss and nausea risk on GLP‑1 drugs, signaling a shift from one‑size‑fits‑all treatment.

New research explains the role of genes and other health factors.

It's the battle against obesity. We all think about food at times, but when the thoughts don't stop, it can be "food noise," and a barrier to weight loss. It's a buzz word among medical professionals ...

Scientists are changing their view of how drugs like Adderall and Ritalin help children with ADHD stay on task. NPR's Jon Hamilton reports on a new study that found the drugs act on brain networks ...

Researchers led by Davide Incarnato at the University of Groningen have demonstrated that the FDA-approved cancer drug mitoxantrone works against RNA not simply by attaching to it, but by forcing it ...

There are currently thought to be about 1.6 million people on weight-loss drugs in the UK. Some people are able to get the injections - the most popular are called Mounjaro and Wegovy - through the ...